Tau aggregation in the hippocampal formation: an ageing or a pathological process? (Q35019484)

5 August 2017

1 reference

title

Tau aggregation in the hippocampal formation: an ageing or a pathological process? (English)

1 reference

5 August 2017

4

Claude-Alain Maurage

1 reference

5 August 2017

André Delacourte

1

1 reference

5 August 2017

Nicolas Sergeant

2

1 reference

5 August 2017

Annick Wattez

3

1 reference

5 August 2017

Florence Lebert

5

1 reference

5 August 2017

Florence Pasquier

6

1 reference

5 August 2017

Jean-Philippe David

7

1 reference

5 August 2017

1 October 2002

1 reference

5 August 2017

Experimental Gerontology

1 reference

5 August 2017

37

1 reference

5 August 2017

1291-1296

1 reference

5 August 2017

10-11

1 reference

Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

Frequency of stages of Alzheimer-related lesions in different age categories

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

Neuropathology of Alzheimer's disease: what is new since A. Alzheimer?

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

Tau pathology: a marker of neurodegenerative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

Diagnosis and staging of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

Prevalence, incidence and duration of Braak's stages in the general population: can we know?

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

Neurofibrillary pathology of Alzheimer's disease and other tauopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

ALZHEIMER'S DISEASE--AN ELECTRON MICROSCOPICAL STUDY

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

The origins of Alzheimer disease: a is for amyloid.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2802%2900141-9

7 January 2021

10.1016/S0531-5565(02)00141-9

Identifiers

DOI

1 reference

5 August 2017

1 reference